United States Files False Claims Act Complaint Against Drug Maker Mallinckrodt. Complaint alleges that company avoided paying hundreds of millions of dollars in Medicaid rebates due to significant drug price increases
BOSTON - The U.S. Attorney's Office announced today that it filed a complaint under the False Claims Act against Mallinckrodt ARD LLC (formerly known as Mallinckrodt ARD, Inc. and previously Questcor Pharmaceuticals, Inc.) (collectively "Mallinckrodt"). The government alleges that Mallinckrodt has violated the False Claims Act by underpaying Medicaid rebates due as a result of large increases in the price of its drug H.P. Acthar Gel ("Acthar").
- Date:March 3, 2020
- Agency:U.S. Attorney's Office, District of Massachusetts
- Criminal and Civil Actions